Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

research

This page shows the latest research news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

This fund is managed by Albion Capital in collaboration with UCL Business (UCLB), UCL’s commercialisation company, which is focused on bringing the world class university’s research in life and ... The company, based in London and New York, has four

Latest news

More from news
Approximately 124 fully matching, plus 1,409 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    The diabetic population shows no sign of reducing any time soon, with research suggesting that the number of diabetics in Europe is expected to grow from 58 million today to 67 ... The need for new drugs follows that trajectory with a report from

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    Talent is diverse, as are the strategies to keep it. While GPG reporting and other recent research have laid bare the challenges across the scientific and pharma industry in terms of

  • Is flexible working the future?

    A glut of research in recent years has already busted this ‘mum myth’being perpetuated by those who fail to see the obvious – that the majority of Britain’s workforce now

  • Doing more with less: when ‘client-centricity’ matters most Doing more with less: when ‘client-centricity’ matters most

    We leverage insights from research to deliver high-quality work that is valuable and relevant to the client and internal stakeholders, including leadership, offering a clear context to show the impact

  • Advancing women in healthcare Advancing women in healthcare

    Professor Melissa Hanna-Brown is Associate Research Fellow at Pfizer UK. Her job involves helping Pfizer’s research and development teams adopt new technology – something which in reality is more of

More from intelligence
Approximately 26 fully matching, plus 495 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    management within the contract research industry. ... He joins Concept from Eurofins, where he was director of business development, responsible for sales of in-vitro and in-vivo pharmacological services for the preclinical research market.

  • Weekly industry appointments Weekly industry appointments

    Leider brings expertise in clinical programme development, quality assessment, health outcomes research, health. ... Fonteyne’s history has also seen him sit on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA) industry

  • Biogen appoints executive VP, corporate development Biogen appoints executive VP, corporate development

    In that role, he led a global team responsible for early science transactions, partnerships and acquisitions across Pfizer's research portfolio.

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    Gavin Corcoran and Michael Hayden join the biopharma. Clinical stage biopharmaceutical group Axovant has appointed Gavin Corcoran as its new executive vice president of research and development. ... Prior to his time at Teva as its president of global

  • Kevin Sin joins GSK Kevin Sin joins GSK

    Kevin Sin has joined GlaxoSmithKline as its senior vice president, head of worldwide business development for pharmaceutical research and development. ... years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said:

More from appointments
Approximately 31 fully matching, plus 720 partially matching documents found.

Latest from PMHub

  • Porterhouse Insights

    Porterhouse Insights. Porterhouse Insights is the research, insight and evidence consultancy of Porterhouse Medical Group. ... Our mission is to optimise decision-making through nimble research methodologies delivering clear insights across the product

  • TransTrans Ltd

    TransTrans Ltd. We provide high quality translations in over 160 language pairings to the Healthcare, pharmaceutical, medical devices and market research sectors through a global network of translators.

  • Porterhouse Medical strengthens the team with three new members.

    Alex is relocating from Scotland, where he completed a research MSc in molecular and clinical medicine focused on castrate-resistant prostate cancer at the University of Edinburgh.

  • Developing advocacy in the pharmaceutical industry.

    Traditional: Identifying academic activities in terms of publication record, volume and impact of literature, conferences, papers and posters; involvement in journals, learned societies, guidelines and clinical research; and engagement with industry.

  • 📈 The Pharma UK Twitter Ranking 2018 [RESEARCH] 📉 

    📈 The Pharma UK Twitter Ranking 2018 [RESEARCH] 📉.

More from PMHub
Approximately 174 fully matching, plus 801 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Quick links

Infographics

Multimedia